CELLECTAR BIOSCIENCES

Cellectar Biosciences, a radiopharmaceutical company, designs and develops products to detect, treat, and monitor various human cancers. Its products include 131I-CLR1404, a compound for cancer therapy. The company's product candidates combine lipid-like molecules and phospholipid ethers analogs with radioisotopes to image or destroy malignant cells. Cellectar Biosciences was formerly known as Cellectar, LLC and changed its name in 2008. The company was founded in 2003 and is based in Madison, Wisconsin.

#SimilarOrganizations #People #Financial #Website #More

CELLECTAR BIOSCIENCES

Social Links:

Facebook

Twitter

Instagram

Youtube

Industry:

Biotechnology Medical Device Therapeutics

Founded:

2002-01-01

Address:

Madison, Wisconsin, United States

Country:

United States

Website Url:

http://www.cellectar.com

Total Employee:

11+

Status:

Active

Contact:

608-441-8120

Email Addresses:

[email protected]

Total Funding:

33.53 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache

Similar Organizations

axcella-logo

Axcella

Axcella is a biotechnology company providing therapeutics development solutions.

checkmate-pharmaceuticals-logo

Checkmate Pharmaceuticals

Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

Current Advisors List

fred-driscoll_image

Fred Driscoll Member, Board of Directors @ Cellectar Biosciences
Board_member

john-neis_image

John Neis Member, Board of Directors @ Cellectar Biosciences
Board_member

stefan-loren_image

Stefan Loren Member, Board of Directors @ Cellectar Biosciences
Board_member

douglas-j-swirsky_image

Douglas J. Swirsky Chairman of the Board @ Cellectar Biosciences
Board_member
2017-04-01

stephen-a-hill_image

Stephen A. Hill Member, Board of Directors @ Cellectar Biosciences
Board_member
2008-04-01

Current Employees Featured

jarrod-longcor_image

Jarrod Longcor
Jarrod Longcor Chief Business Officer & SVP Operations @ Cellectar Biosciences
Chief Business Officer & SVP Operations
2017-09-01

charles-bernhard_image

Charles Bernhard
Charles Bernhard Interim / Fractional Chief Financial Officer & Controller @ Cellectar Biosciences
Interim / Fractional Chief Financial Officer & Controller

not_available_image

Dov Elefant
Dov Elefant Vice President and Chief Financial Officer @ Cellectar Biosciences
Vice President and Chief Financial Officer

james-caruso_image

James Caruso
James Caruso President, Chief Executive Officer & Director @ Cellectar Biosciences
President, Chief Executive Officer & Director
2015-06-01

Founder

jamey-weichert_image

Jamey Weichert

Stock Details

Company's stock symbol is NASDAQ:CLRB

Acquisitions List

Date	Company	Article	Price
2011-04-12	Novelos Therapeutics	Novelos Therapeutics acquired by Cellectar Biosciences	5.13 M USD

Investors List

national-cancer-institute_image

Official Site Inspections

http://www.cellectar.com Semrush global rank: 3.34 M Semrush visits lastest month: 4.79 K

Host Informations
Whois Informations

Loading ...